Active ingredientCeftolozaneCat. No. P-C107-001CAS 1852466-67-1Family · Pharmaceutical analytical standards
Ceftolozane
An injectable cephalosporin used in combination with tazobactam, a beta-lactamase inhibitor: approved in 2014 in the United States and in 2015 in Europe, it is used for complicated urinary and intra-abdominal infections and for hospital-acquired pneumonia. This family brings together the active ingredient and other impurities.
Did you know?In the laboratory it was called FR264205, then CXA-101: it was studied in particular against strains of Pseudomonas aeruginosa resistant to carbapenems and to several classes of antibiotics.
Go to the active ingredient →Active ingredientCeftolozaneCat. No. P-C107-001CAS 1852466-67-1
ImpurityCeftolozane Impurity 1 TrihydrochlorideCat. No. P-C107-005CAS 689294-59-5
ImpurityCeftolozane Impurity 2Cat. No. P-C107-006CAS 474956-63-3
ImpurityCeftolozane Impurity 3Cat. No. P-C107-007CAS 56040-80-3
ImpurityCeftolozane Impurity 4Cat. No. P-C107-008
ImpurityCeftolozane Impurity 5Cat. No. P-C107-009CAS 1956303-47-1
ImpurityCeftolozane Impurity 6Cat. No. P-C107-010CAS 76028-96-1
ImpurityCeftolozane Impurity 7Cat. No. P-C107-011CAS 1956303-56-2
ImpurityCeftolozane Impurity 8Cat. No. P-C107-012CAS 1956303-48-2
ImpurityCeftolozane Impurity 9Cat. No. P-C107-013CAS 1956303-49-3
ImpurityCeftolozane Impurity 10Cat. No. P-C107-014CAS 1956303-44-8
ImpurityCeftolozane Impurity 11Cat. No. P-C107-015
ImpurityCeftolozane Impurity 12Cat. No. P-C107-016CAS 47288-83-5
ImpurityCeftolozane Impurity 13Cat. No. P-C107-017CAS 1950566-51-4
ImpurityCeftolozane Impurity 14Cat. No. P-C107-018CAS 689293-67-2
ImpurityCeftolozane Impurity 15Cat. No. P-C107-019CAS 1956303-46-0
ImpurityCeftolozane Impurity 16Cat. No. P-C107-020CAS 1956303-45-9No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.